Back to Company Profile
Alpha

Alpha Profiles · Company Profile

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases.

https://registry.alpha.ac/companies/elicio-therapeutics-inc

Elicio Therapeutics, Inc. logo
Entity
Public listing published
Primary listing
NASDAQ: ELTX
Verification
Partially verified
Last reviewed
2026-09-16T04:46:48.037677+00:00

Overview

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing muta

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

0 public records

Executive roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no executive team.

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

9 public records

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-09-16T04:46:48.037677+00:00

Generated 2026-09-16T11:02:39.991Z

Data as of 2026-09-16T04:46:48.037677+00:00

https://registry.alpha.ac/companies/elicio-therapeutics-inc